# RISEDRONATE SODIUM
> **ANDA203822** · Abbreviated New Drug Application (Generic) · Sponsor: ZYDUS PHARMS · Approved 2018-09-11
## Drug
- **FDA Application Number:** ANDA203822
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** RISEDRONATE SODIUM
- **Generic name:** Risedronate Sodium
- **Active ingredients:** RISEDRONATE SODIUM
- **Dosage form:** TABLET, DELAYED RELEASE
- **Route:** ORAL
- **Marketing status:** Discontinued
- **Sponsor:** ZYDUS PHARMS
- **First approval:** 2018-09-11
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=203822)
---
*MORVS · CC0 1.0*